IL236172B - Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases - Google Patents

Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases

Info

Publication number
IL236172B
IL236172B IL236172A IL23617214A IL236172B IL 236172 B IL236172 B IL 236172B IL 236172 A IL236172 A IL 236172A IL 23617214 A IL23617214 A IL 23617214A IL 236172 B IL236172 B IL 236172B
Authority
IL
Israel
Prior art keywords
neuroinflammatory
bmp
signaling
treatment
neurodegenerative diseases
Prior art date
Application number
IL236172A
Other languages
Hebrew (he)
Other versions
IL236172A0 (en
Original Assignee
The Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2013/050503 external-priority patent/WO2013186777A2/en
Application filed by The Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center Fund filed Critical The Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center Fund
Priority to IL236172A priority Critical patent/IL236172B/en
Publication of IL236172A0 publication Critical patent/IL236172A0/en
Publication of IL236172B publication Critical patent/IL236172B/en

Links

IL236172A 2012-06-14 2014-12-11 Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases IL236172B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL236172A IL236172B (en) 2012-06-14 2014-12-11 Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659510P 2012-06-14 2012-06-14
PCT/IL2013/050503 WO2013186777A2 (en) 2012-06-14 2013-06-12 Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
IL236172A IL236172B (en) 2012-06-14 2014-12-11 Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases

Publications (2)

Publication Number Publication Date
IL236172A0 IL236172A0 (en) 2015-01-29
IL236172B true IL236172B (en) 2019-05-30

Family

ID=52440247

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236172A IL236172B (en) 2012-06-14 2014-12-11 Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases

Country Status (1)

Country Link
IL (1) IL236172B (en)

Also Published As

Publication number Publication date
IL236172A0 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
WO2013186777A3 (en) Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
IL240420A0 (en) Endoprosthesis for the partial replacement of the human pelvic bone
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP2890440A4 (en) Devices and methods for the treatment of vascular disease
IL239368A0 (en) Ppar-sparing thiazolidiones and combinations for the treatment of neurodegenerative diseases
HK1215358A1 (en) Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases
HUE048924T2 (en) Therapeutic use of bone morphogenetic proteins
EP2968470A4 (en) Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
IL244808A0 (en) Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
IL239629B (en) Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
IL235410A0 (en) Oval platform dental implant system and it's components
ZA201603118B (en) Compounds for use in prevention and treatment of neurodegenerative diseases and pain
PT3120852T (en) Preventive and/or therapeutic agent for immune diseases
IL239078A0 (en) Protein for use in the treatment of ocular diseases
EP2903436A4 (en) Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
EP3397267A4 (en) Peptides for the treatment of resorptive bone disease
IL273834A (en) Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
IL236172A0 (en) Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
PT3471788T (en) Biological prosthesis intended for the treatment of parastomal hernias
GB201219696D0 (en) Agents for the prevention and/or treatment of central nervous system damamge

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed